Detalhe da pesquisa
1.
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.
Oncologist
; 29(4): e447-e454, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37971409
2.
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps.
Cancer Immunol Immunother
; 72(10): 3363-3376, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37525065
3.
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients.
J Transl Med
; 21(1): 318, 2023 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37170241
4.
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
J Transl Med
; 21(1): 140, 2023 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36823670
5.
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.
Int J Mol Sci
; 24(5)2023 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36902351
6.
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation.
J Transl Med
; 19(1): 17, 2021 01 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33407577
7.
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma.
Int J Mol Sci
; 22(4)2021 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33670365
8.
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients.
J Transl Med
; 18(1): 121, 2020 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32160899
9.
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study.
Cancer Immunol Immunother
; 68(1): 97-107, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30311027
10.
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.
J Transl Med
; 15(1): 244, 2017 12 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29202855
11.
Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave.
J Transl Med
; 19(1): 93, 2021 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33653336
12.
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.
J Transl Med
; 13: 37, 2015 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-25627962
13.
Discrepant alterations in main candidate genes among multiple primary melanomas.
J Transl Med
; 12: 117, 2014 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-24885594
14.
Methylationsensitive restriction enzymedroplet digital PCR assay for the onestep highly sensitive analysis of DNA methylation hotspots.
Int J Mol Med
; 53(5)2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38488030
15.
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
Cell Death Dis
; 15(3): 208, 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38472212
16.
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
J Transl Med
; 11: 54, 2013 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-23452415
17.
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.
J Transl Med
; 11: 202, 2013 Aug 29.
Artigo
Inglês
| MEDLINE | ID: mdl-23987572
18.
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.
Eur J Cancer
; 189: 112923, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37301715
19.
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study.
Front Oncol
; 13: 1107307, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36845751
20.
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
J Exp Clin Cancer Res
; 42(1): 317, 2023 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38008717